ABUS
NASDAQ · Biotechnology
Arbutus Biopharma Corp
$4.34
-0.01 (-0.23%)
Open$4.34
Previous Close$4.35
Day High$4.40
Day Low$4.31
52W High$5.10
52W Low$2.94
Volume—
Avg Volume2.06M
Market Cap854.72M
P/E Ratio—
EPS$-0.18
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,080.9% upside
Current
$4.34
$4.34
Target
$51.25
$51.25
$34.47
$51.25 avg
$59.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.28M | 20.05M | 146.67M |
| Net Income | -33,955,620 | -42,921,429 | -16,611,843 |
| Profit Margin | -237.9% | -226.0% | -11.3% |
| EBITDA | -37,646,448 | -50,230,513 | -23,689,130 |
| Free Cash Flow | — | — | -19,958,595 |
| Rev Growth | -28.8% | -28.8% | -8.1% |
| Debt/Equity | 0.04 | 0.04 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |